Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | serotonin receptor | 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled | 366 aa | 399 aa | 25.8 % |
Brugia malayi | AT19640p | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | 390 aa | 335 aa | 21.8 % |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Concentration of max response (functional) | = 0 M | In vitro concentration of maximum contractile response in rabbit saphenous vein; 10E-4 | ChEMBL. | 12825944 |
Efficacy (functional) | = 1.1 | In vivo efficacy in neurogenic plasma protein extravasation screen using guinea pig neurogenic PPE assay (1 ng/kg, po) at 1 h postdose | ChEMBL. | 12825944 |
Efficacy (functional) | = 1.6 | In vivo efficacy in neurogenic plasma protein extravasation screen using guinea pig neurogenic PPE assay (1 ng/kg, po) at 24 h postdose | ChEMBL. | 12825944 |
Ki (binding) | = 7.3 nM | In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1F receptor | ChEMBL. | 12825944 |
Ki (binding) | = 7.3 nM | In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1F receptor | ChEMBL. | 12825944 |
Ki (binding) | = 72 nM | In vitro binding affinity of the compound was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor | ChEMBL. | 12825944 |
Ki (binding) | = 72 nM | In vitro binding affinity of the compound was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor | ChEMBL. | 12825944 |
Ki (binding) | = 820 nM | In vitro binding affinity of the compound was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor | ChEMBL. | 12825944 |
Ki (binding) | = 820 nM | In vitro binding affinity of the compound was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor | ChEMBL. | 12825944 |
Ki (binding) | = 1000 nM | In vitro binding affinity of the compound was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor | ChEMBL. | 12825944 |
Ki (binding) | = 1000 nM | In vitro binding affinity of the compound was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor | ChEMBL. | 12825944 |
Response (functional) | = 0 % | In vitro contractile response in rabbit saphenous vein | ChEMBL. | 12825944 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.